Showing results (21-30 of 47) with videos related to

Sort By:
Pageof 5
Journal of Neurology, Neurosurgery, and Psychiatry|October 10, 2025
Extended window of relapse recovery in RRMS: an analysis of the DECIDE datasetJop Mostert, Eva M Strijbis, Miguel D'Haeseleer, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 20, 2026
Diminishing returns of disease-modifying treatment in older participants of MS clinical trialsEva Strijbis, Jop Mostert, Miguel D'Haeseleer, et al.
Annals of Clinical and Translational Neurology|February 23, 2021
Safety evaluation of shorter infusion for ocrelizumab in a substudy of the Phase IIIb CHORDS trialRobert A Bermel, Emmanuelle Waubant, Gabriel Pardo, et al.
Journal of Neurology|April 12, 2025
Measuring cognitive change in secondary progressive MS: an analysis of the ASCEND cognition substudyVictoria Leavitt, Jop Mostert, Jacynthe Comtois, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 9, 2024
Selecting Informative Patients for Phase 2 Progressive Trials in MS: Design Considerations for Phase 2 Clinical Trials in Progressive MSMarcus W Koch, Carlos Camara-Lemarroy, Eva Strijbis, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|January 28, 2026
Breaking the PROMISE: poor association between brain volume loss and clinical disability worsening over 2 years of follow-up in primary progressive multiple sclerosisMarcus Koch, Jop Mostert, Eva M Strijbis, et al.
Neurology|February 17, 2025
Utility of Progression Independent of Relapse Activity as a Trial Outcome in Relapsing-Remitting Multiple SclerosisEva M M Strijbis, Jop Mostert, Jacynthe Comtois, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|May 12, 2023
Association of age and inflammatory disease activity in the pivotal natalizumab clinical trials in relapsing-remitting multiple sclerosisEva M Strijbis, Eline Coerver, Jop Mostert, et al.
Radiology|September 11, 2014
Fast whole-brain three-dimensional macromolecular proton fraction mapping in multiple sclerosisVasily L Yarnykh, James D Bowen, Alexey Samsonov, et al.
Pageof 5